501 CANAL BLVD., RICHMOND, CA
News, Letter Re Change in Certifying Accountant
Material disclosure
Amended material disclosure
Reports Recent Business Highlights And First Quarter 2026 Financial Results
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Sangamo Therapeutics Enters Underwriting Agreement for Stock Offering
Other Events
Earnings Release
Q1
Amended Annual Report
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Free Writing Prospectus
Submission Upload
Correspondence
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement